SCHEMBL5800869

SCHEMBL5800869

CC(=O)OC(=O)c1ccccc1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.54
CES1 P23141 1/20 0.54
ALDH1A1 P00352 4/20 0.50
KMT2A Q03164 3/20 0.50
ITGB1 P05556 1/20 0.50
ITGA5 P08648 1/20 0.50
ALOX15 P16050 1/20 0.50
GAA P10253 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 2/20 0.45
CYP1A2 P05177 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP2D6 P10635 1/20 0.44
CASP3 P42574 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
MAPT P10636 3/20 0.44
ADRB2 P07550 2/20 0.44
ADRB1 P08588 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8378855 0.87 CES2 (0.62) CES2CES1ALDH1A1KMT2AALOX15
SCHEMBL2778 0.85 TSHR (0.52) ALDH1A1ITGB1ITGA5ALOX15NPC1
SCHEMBL30084385 0.85 TSHR (0.52) ALDH1A1ITGB1ITGA5ALOX15NPC1
SCHEMBL28206063 0.83 TSHR (0.50) ALDH1A1ITGB1ITGA5ALOX15NPC1
SCHEMBL27931437 0.83 TSHR (0.50) ALDH1A1ITGB1ITGA5ALOX15NPC1
SCHEMBL1896602 0.83 TSHR (0.50) ALDH1A1ITGB1ITGA5ALOX15NPC1
Acetone SCHEMBL29281281 0.83 TSHR (0.50) ALDH1A1ITGB1ITGA5ALOX15NPC1
SCHEMBL6383298 0.83 TSHR (0.50) ALDH1A1ITGB1ITGA5ALOX15NPC1
Acetic Acid SCHEMBL28536661 0.81 TSHR (0.48) ALDH1A1ITGB1ITGA5ALOX15CYP1A2
SCHEMBL27885277 0.81 CES2 (0.50) CES2CES1ALDH1A1KMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107677735-A A kind of HPLC analysis methods of (S) 2 aminopropanol 上海朴颐化学科技有限公司 2018-02-09 CN claimed
US-20060111369-A1 Synthesis, characterization and biological action of optically active isomers of floxacins SOMBERG JOHN C 2006-05-25 US claimed
WO-2006052264-A2 SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL ACTION OF OPTICALLY ACTIVE ISOMERS OF FLOXACINS SOMBERG JOHN CHARIN (US) 2006-05-18 WO claimed
CN-114555604-A Pharmaceutical compounds 瑞威有限公司 2022-05-27 CN disclosed
CN-110552018-B Method for synthesizing 1-naphthol compound based on electrochemical intermolecular cyclization 广西师范大学 2021-03-05 CN disclosed
CN-107548397-B Kv1.3 inhibitors and medical uses thereof 4SC股份公司 2020-12-29 CN disclosed
CN-107548396-B Kv1.3 inhibitors and medical uses thereof 4SC股份公司 2020-04-28 CN disclosed
CN-110552018-A Method for synthesizing 1-naphthol compound based on electrochemical intermolecular cyclization UNIV GUANGXI NORMAL 2019-12-10 CN disclosed
CN-107677735-A A kind of HPLC analysis methods of (S) 2 aminopropanol 上海朴颐化学科技有限公司 2018-02-09 CN disclosed
US-20060111369-A1 Synthesis, characterization and biological action of optically active isomers of floxacins SOMBERG JOHN C 2006-05-25 US disclosed
WO-2006052264-A2 SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL ACTION OF OPTICALLY ACTIVE ISOMERS OF FLOXACINS SOMBERG JOHN CHARIN (US) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111369-A1 Synthesis, characterization and biological action of optically active isomers of floxacins TNNI3, TNNC1, TNNT2 CES2 2909/4885CES1 1987/4885ALDH1A1 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.